カテゴリー： QYResearch, 世界, 医療/バイオ

心房中隔閉塞装置のグローバル市場2023年：吸収性、非吸収性

◆英語タイトル：Global Atrial Septal Occlusion Device Market Research Report 2023

QYResearchが発行した調査報告書（QYR23MA7643）◆商品コード：QYR23MA7643
◆発行会社（リサーチ会社）：QYResearch
◆発行日：2023年3月
◆ページ数：90
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,900 ⇒換算￥440,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD4,350 ⇒換算￥661,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD5,800 ⇒換算￥881,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本調査レポートは世界の心房中隔閉塞装置市場について調査・分析し、世界の心房中隔閉塞装置市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（吸収性、非吸収性）、用途別セグメント分析（子供、大人）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Abbott、GORE、atHeart Medical、MicroPort Group、Lifetech Scientific、Occlutech、Lepu Medical Technology、WEGO、ScienTech Medical、Shanghai MicroPort MedBotなどが含まれています。世界の心房中隔閉塞装置市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、心房中隔閉塞装置市場規模を推定する際に考慮しました。

・心房中隔閉塞装置市場の概要
- 製品の定義
- 心房中隔閉塞装置のタイプ別セグメント
- 世界の心房中隔閉塞装置市場規模：タイプ別分析（吸収性、非吸収性）
- 心房中隔閉塞装置の用途別セグメント
- 世界の心房中隔閉塞装置市場規模：用途別分析（子供、大人）
- 世界の心房中隔閉塞装置市場規模予測（2018年-2029年）
- 心房中隔閉塞装置の平均価格推移（2018年-2029年）
- 前提条件と制限事項

・メーカー別競争状況
- メーカー別市場シェア
- 世界の主要メーカー、業界ランキング分析
- メーカー別平均価格
- 心房中隔閉塞装置市場の競争状況およびトレンド

・心房中隔閉塞装置の地域別市場規模
- 北米の心房中隔閉塞装置市場規模（2018年-2029年）
- アメリカの心房中隔閉塞装置市場規模（2018年-2029年）
- ヨーロッパの心房中隔閉塞装置市場規模（2018年-2029年）
- アジア太平洋の心房中隔閉塞装置市場規模（2018年-2029年）
- 中国の心房中隔閉塞装置市場規模（2018年-2029年）
- 日本の心房中隔閉塞装置市場規模（2018年-2029年）
- 韓国の心房中隔閉塞装置市場規模（2018年-2029年）
- インドの心房中隔閉塞装置市場規模（2018年-2029年）
- オーストラリアの心房中隔閉塞装置市場規模（2018年-2029年）
- 中南米の心房中隔閉塞装置市場規模（2018年-2029年）
- 中東・アフリカの心房中隔閉塞装置市場規模（2018年-2029年）

・タイプ別セグメント：吸収性、非吸収性
- 世界の心房中隔閉塞装置のタイプ別販売量（2018年-2023年）
- 世界の心房中隔閉塞装置のタイプ別売上（2018年-2023年）
- 世界の心房中隔閉塞装置のタイプ別価格

・用途別セグメント：子供、大人
- 世界の心房中隔閉塞装置の用途別販売量（2018年-2023年）
- 世界の心房中隔閉塞装置の用途別売上（2018年-2023年）
- 世界の心房中隔閉塞装置の用途別価格

・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向
Abbott、GORE、atHeart Medical、MicroPort Group、Lifetech Scientific、Occlutech、Lepu Medical Technology、WEGO、ScienTech Medical、Shanghai MicroPort MedBot

・産業チェーンと販売チャネルの分析
- 心房中隔閉塞装置産業チェーン分析
- 心房中隔閉塞装置の主要原材料
- 心房中隔閉塞装置の販売チャネル
- 心房中隔閉塞装置のディストリビューター
- 心房中隔閉塞装置の主要顧客

・心房中隔閉塞装置市場ダイナミクス
- 心房中隔閉塞装置の業界動向
- 心房中隔閉塞装置市場の成長ドライバ、課題、阻害要因

・調査成果および結論

・調査方法とデータソース

Highlights
The global Atrial Septal Occlusion Device market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Atrial Septal Occlusion Device is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Atrial Septal Occlusion Device is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Atrial Septal Occlusion Device include Abbott, GORE, atHeart Medical, MicroPort Group, Lifetech Scientific, Occlutech, Lepu Medical Technology, WEGO and ScienTech Medical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Atrial Septal Occlusion Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Atrial Septal Occlusion Device.
The Atrial Septal Occlusion Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Atrial Septal Occlusion Device market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Atrial Septal Occlusion Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Abbott
GORE
atHeart Medical
MicroPort Group
Lifetech Scientific
Occlutech
Lepu Medical Technology
WEGO
ScienTech Medical
Shanghai MicroPort MedBot
Segment by Type
by Product Type
Absorbable
Unabsorbable
by Waist Diameter
Below 10 mm
10 – 30 mm
Above 30 mm
Segment by Application
Children
Adult
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Atrial Septal Occlusion Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Atrial Septal Occlusion Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Atrial Septal Occlusion Device Market Overview
1.1 Product Overview and Scope of Atrial Septal Occlusion Device
1.2 Atrial Septal Occlusion Device Segment by Product Type
1.2.1 Global Atrial Septal Occlusion Device Market Value Comparison by Product Type (2023-2029)
1.2.2 Absorbable
1.2.3 Unabsorbable
1.3 Atrial Septal Occlusion Device Segment by Application
1.3.1 Global Atrial Septal Occlusion Device Market Value by Application: (2023-2029)
1.3.2 Children
1.3.3 Adult
1.4 Global Atrial Septal Occlusion Device Market Size Estimates and Forecasts
1.4.1 Global Atrial Septal Occlusion Device Revenue 2018-2029
1.4.2 Global Atrial Septal Occlusion Device Sales 2018-2029
1.4.3 Global Atrial Septal Occlusion Device Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Atrial Septal Occlusion Device Market Competition by Manufacturers
2.1 Global Atrial Septal Occlusion Device Sales Market Share by Manufacturers (2018-2023)
2.2 Global Atrial Septal Occlusion Device Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Atrial Septal Occlusion Device Average Price by Manufacturers (2018-2023)
2.4 Global Atrial Septal Occlusion Device Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Atrial Septal Occlusion Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Atrial Septal Occlusion Device, Product Type & Application
2.7 Atrial Septal Occlusion Device Market Competitive Situation and Trends
2.7.1 Atrial Septal Occlusion Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Atrial Septal Occlusion Device Players Market Share by Revenue
2.7.3 Global Atrial Septal Occlusion Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Atrial Septal Occlusion Device Retrospective Market Scenario by Region
3.1 Global Atrial Septal Occlusion Device Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Atrial Septal Occlusion Device Global Atrial Septal Occlusion Device Sales by Region: 2018-2029
3.2.1 Global Atrial Septal Occlusion Device Sales by Region: 2018-2023
3.2.2 Global Atrial Septal Occlusion Device Sales by Region: 2024-2029
3.3 Global Atrial Septal Occlusion Device Global Atrial Septal Occlusion Device Revenue by Region: 2018-2029
3.3.1 Global Atrial Septal Occlusion Device Revenue by Region: 2018-2023
3.3.2 Global Atrial Septal Occlusion Device Revenue by Region: 2024-2029
3.4 North America Atrial Septal Occlusion Device Market Facts & Figures by Country
3.4.1 North America Atrial Septal Occlusion Device Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Atrial Septal Occlusion Device Sales by Country (2018-2029)
3.4.3 North America Atrial Septal Occlusion Device Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Atrial Septal Occlusion Device Market Facts & Figures by Country
3.5.1 Europe Atrial Septal Occlusion Device Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Atrial Septal Occlusion Device Sales by Country (2018-2029)
3.5.3 Europe Atrial Septal Occlusion Device Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atrial Septal Occlusion Device Market Facts & Figures by Country
3.6.1 Asia Pacific Atrial Septal Occlusion Device Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Atrial Septal Occlusion Device Sales by Country (2018-2029)
3.6.3 Asia Pacific Atrial Septal Occlusion Device Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Atrial Septal Occlusion Device Market Facts & Figures by Country
3.7.1 Latin America Atrial Septal Occlusion Device Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Atrial Septal Occlusion Device Sales by Country (2018-2029)
3.7.3 Latin America Atrial Septal Occlusion Device Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Atrial Septal Occlusion Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Atrial Septal Occlusion Device Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Atrial Septal Occlusion Device Sales by Country (2018-2029)
3.8.3 Middle East and Africa Atrial Septal Occlusion Device Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Atrial Septal Occlusion Device Sales by Type (2018-2029)
4.1.1 Global Atrial Septal Occlusion Device Sales by Type (2018-2023)
4.1.2 Global Atrial Septal Occlusion Device Sales by Type (2024-2029)
4.1.3 Global Atrial Septal Occlusion Device Sales Market Share by Type (2018-2029)
4.2 Global Atrial Septal Occlusion Device Revenue by Type (2018-2029)
4.2.1 Global Atrial Septal Occlusion Device Revenue by Type (2018-2023)
4.2.2 Global Atrial Septal Occlusion Device Revenue by Type (2024-2029)
4.2.3 Global Atrial Septal Occlusion Device Revenue Market Share by Type (2018-2029)
4.3 Global Atrial Septal Occlusion Device Price by Type (2018-2029)
5 Segment by Application
5.1 Global Atrial Septal Occlusion Device Sales by Application (2018-2029)
5.1.1 Global Atrial Septal Occlusion Device Sales by Application (2018-2023)
5.1.2 Global Atrial Septal Occlusion Device Sales by Application (2024-2029)
5.1.3 Global Atrial Septal Occlusion Device Sales Market Share by Application (2018-2029)
5.2 Global Atrial Septal Occlusion Device Revenue by Application (2018-2029)
5.2.1 Global Atrial Septal Occlusion Device Revenue by Application (2018-2023)
5.2.2 Global Atrial Septal Occlusion Device Revenue by Application (2024-2029)
5.2.3 Global Atrial Septal Occlusion Device Revenue Market Share by Application (2018-2029)
5.3 Global Atrial Septal Occlusion Device Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Atrial Septal Occlusion Device Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Atrial Septal Occlusion Device Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 GORE
6.2.1 GORE Corporation Information
6.2.2 GORE Description and Business Overview
6.2.3 GORE Atrial Septal Occlusion Device Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GORE Atrial Septal Occlusion Device Product Portfolio
6.2.5 GORE Recent Developments/Updates
6.3 atHeart Medical
6.3.1 atHeart Medical Corporation Information
6.3.2 atHeart Medical Description and Business Overview
6.3.3 atHeart Medical Atrial Septal Occlusion Device Sales, Revenue and Gross Margin (2018-2023)
6.3.4 atHeart Medical Atrial Septal Occlusion Device Product Portfolio
6.3.5 atHeart Medical Recent Developments/Updates
6.4 MicroPort Group
6.4.1 MicroPort Group Corporation Information
6.4.2 MicroPort Group Description and Business Overview
6.4.3 MicroPort Group Atrial Septal Occlusion Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 MicroPort Group Atrial Septal Occlusion Device Product Portfolio
6.4.5 MicroPort Group Recent Developments/Updates
6.5 Lifetech Scientific
6.5.1 Lifetech Scientific Corporation Information
6.5.2 Lifetech Scientific Description and Business Overview
6.5.3 Lifetech Scientific Atrial Septal Occlusion Device Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Lifetech Scientific Atrial Septal Occlusion Device Product Portfolio
6.5.5 Lifetech Scientific Recent Developments/Updates
6.6 Occlutech
6.6.1 Occlutech Corporation Information
6.6.2 Occlutech Description and Business Overview
6.6.3 Occlutech Atrial Septal Occlusion Device Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Occlutech Atrial Septal Occlusion Device Product Portfolio
6.6.5 Occlutech Recent Developments/Updates
6.7 Lepu Medical Technology
6.6.1 Lepu Medical Technology Corporation Information
6.6.2 Lepu Medical Technology Description and Business Overview
6.6.3 Lepu Medical Technology Atrial Septal Occlusion Device Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Lepu Medical Technology Atrial Septal Occlusion Device Product Portfolio
6.7.5 Lepu Medical Technology Recent Developments/Updates
6.8 WEGO
6.8.1 WEGO Corporation Information
6.8.2 WEGO Description and Business Overview
6.8.3 WEGO Atrial Septal Occlusion Device Sales, Revenue and Gross Margin (2018-2023)
6.8.4 WEGO Atrial Septal Occlusion Device Product Portfolio
6.8.5 WEGO Recent Developments/Updates
6.9 ScienTech Medical
6.9.1 ScienTech Medical Corporation Information
6.9.2 ScienTech Medical Description and Business Overview
6.9.3 ScienTech Medical Atrial Septal Occlusion Device Sales, Revenue and Gross Margin (2018-2023)
6.9.4 ScienTech Medical Atrial Septal Occlusion Device Product Portfolio
6.9.5 ScienTech Medical Recent Developments/Updates
6.10 Shanghai MicroPort MedBot
6.10.1 Shanghai MicroPort MedBot Corporation Information
6.10.2 Shanghai MicroPort MedBot Description and Business Overview
6.10.3 Shanghai MicroPort MedBot Atrial Septal Occlusion Device Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Shanghai MicroPort MedBot Atrial Septal Occlusion Device Product Portfolio
6.10.5 Shanghai MicroPort MedBot Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atrial Septal Occlusion Device Industry Chain Analysis
7.2 Atrial Septal Occlusion Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atrial Septal Occlusion Device Production Mode & Process
7.4 Atrial Septal Occlusion Device Sales and Marketing
7.4.1 Atrial Septal Occlusion Device Sales Channels
7.4.2 Atrial Septal Occlusion Device Distributors
7.5 Atrial Septal Occlusion Device Customers
8 Atrial Septal Occlusion Device Market Dynamics
8.1 Atrial Septal Occlusion Device Industry Trends
8.2 Atrial Septal Occlusion Device Market Drivers
8.3 Atrial Septal Occlusion Device Market Challenges
8.4 Atrial Septal Occlusion Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 心房中隔閉塞装置のグローバル市場2023年：吸収性、非吸収性(Global Atrial Septal Occlusion Device Market Research Report 2023)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 非外傷性閉塞装置のグローバル市場予測2023-2029
  • 心房中隔欠損閉塞症（ASD）のグローバル市場予測2023-2029
  • 医療用オクルーダーデバイスのグローバル市場2023年：ASDオクルーダー、VSDオクルーダー、PDAオクルーダー、PFOオクルーダー、LAAオクルーダー
  • 世界の閉塞バルーンカテーテル市場インサイト及び予測（6 F、7 F、8 F、10 F、その他）
  • 世界の心房細動凍結融解術装置市場インサイト及び予測（心房細動・粗動、頻脈性不整脈）